Viewing Study NCT00740805


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2025-12-26 @ 1:58 AM
Study NCT ID: NCT00740805
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-06
First Post: 2008-08-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Veliparib, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Non-Hodgkin Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module